Article
Mast cell activation syndrome as a significant comorbidity in sickle cell disease.
The American journal of the medical sciences - 1 Dec 2014
Afrin Lawrence B
Abstract excerpt
Some sickle cell anemia (SCA) patients suffer significantly worse phenotypes than others. Causes of such disparities are incompletely understood. Comorbid chronic inflammation likely is a factor. Recently, mast cell (MC) activation (creating an inflammatory state) was found to be a significant factor in sickle pathobiology and pain in a murine SCA model. Also, a new realm of relatively noncytoproliferative MC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
